Funded by
the European Union
Recently, EuCARE research was featured at EBMLive 2026 in Oxford through two oral presentations showcasing studies developed within the consortium. Giulia Doi presented a meta-analysis
Another successful edition of the European Meeting on HIV & Hepatitis (Barcelona, Spain) has come to an end. As an EMHH 2026 Endorser, EuCARE was
🦠 SARS-CoV-2 and Ebola virus are both zoonotic pathogens, but they differ significantly in how they spread, the disease they cause and their public health
The 24th European Meeting on HIV & Hepatitis (EMHH 2026) will take place in Barcelona, Spain, from 10–12 June 2026. Bringing together clinicians, researchers and
How do SARS-COV-2 variants, coupled with other factors, influence the short- and long-term clinical course of COVID-19? Is the efficacy of vaccines or diagnostic tests affected as new variants emerge? Does treatment efficacy vary among variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?
34 institutions from 4 continents collaborate to find answers to these and other crucial questions and to create a sustainable network to promptly tackle similar issues in the future.
FUNDED BY THE EC UNDER HORIZON-HLTH-2021-CORONA-01
- GRANT AGREEMENT NO 101046016
Get to know the project and its scope
Find out all the media news about the EuCARE Project.
